Breakpoints cover image

#35 – Oral Beta-Lactams, Are We Serious?

Breakpoints

00:00

How to Use Oral Beta Lactams to Improve Treatment Decisions

Jesse: I have a couple of ideas, research ideas that maybe some people can jump on. One would be pharmacokinetic models for a wider variety of patients and doses of these drugs. The other one is correlating the susceptibility that we receive to the oral cephalosporins that we'd actually be using. We talked about how you might just get a cepHalosene susceptibility or a cep Halosene MIC. And then we're extrapolating that to cep halosene or extrapolating it to cepyroxine. So those are my pearls. Thank you, Jesse, for all these wonderful ideas on research and giving inspiring some

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app